Physical Therapist Management of Patients With Suspected or Confirmed Osteoporosis: A Clinical Practice Guideline From the Academy of Geriatric Physical Therapy.

"All individuals whose names appear as authors of or contributors to this CPG filed a disclosure statement as part of the grant submission process. In addition, prior to and during the development of this CPG, development group members routinely disclosed conflicts of interest in writing to APTA Geriatrics using the International Committee of Medical Journal Editors (ICMJE) Form for Disclosure of Potential Conflicts of Interest. Each of the guideline development group (GDG) members was asked to disclose any existing or potential conflicts of interest—including financial relationships with pharmaceutical, medical device, or biotechnology companies—prior to being included in the group and routinely thereafter. All guideline development group members report grants from APTA Geriatrics and APTA during the conduct of the work. Dr Hartley served as a member of the board of directors of APTA Geriatrics from during the conduct of this work. He received no compensation for this position; however, the Academy funded travel to annual meeting(s). Dr Betz served as chair of the Bone Health Special Interest Group of APTA Geriatrics from 2009 to 2020. She received no compensation for this position; however, the Academy funded some expenses related to travel to an annual meeting."

"This clinical practice guideline (CPG) was supported by a grant from the American Physical Therapy Association and by the American Physical Therapy Association Academy of Geriatric Physical Therapy (APTA Geriatrics), which received no funding from outside commercial sources to support the guideline's development. The views of the funding body have not influenced the content of the guideline. All individuals whose names appear as authors of or contributors to this CPG filed a disclosure statement as part of the grant submission process. In addition, prior to and during the development of this CPG, development group members routinely disclosed conflicts of interest in writing to APTA Geriatrics using the International Committee of Medical Journal Editors (ICMJE) Form for Disclosure of Potential Conflicts of Interest. Each of the guideline development group (GDG) members was asked to disclose any existing or potential conflicts of interest—including financial relationships with pharmaceutical, medical device, or biotechnology companies—prior to being included in the group and routinely thereafter. All guideline development group members report grants from APTA Geriatrics and APTA during the conduct of the work. Dr Hartley served as a member of the board of directors of APTA Geriatrics from during the conduct of this work. He received no compensation for this position; however, the Academy funded travel to annual meeting(s). Dr Betz served as chair of the Bone Health Special Interest Group of APTA Geriatrics from 2009 to 2020. She received no compensation for this position; however, the Academy funded some expenses related to travel to an annual meeting."